The emerging evidence for the role of elevated levels of triglyceride-rich lipoprotein remnants (TLRs) in raising the risk of atherosclerotic cardiovascular disease (ASCVD) events, along with emerging lipid-lowering therapies for cardiovascular risk management, were the subject of a Focus Seminar published Oct. 25 in the Journal of the American College of Cardiology.
↧